EY 08208/EY/NEI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1992	3
1994	1
1997	1
1998	1
1999	1
2000	3
2001	1
2003	3
2004	3
2005	1
2006	2
2007	1
2008	3
2009	1
2021	0

1

Functional assessment of glaucoma.

Sample PA, Johnson CA. Sample PA, et al. J Glaucoma. 2001 Oct;10(5 Suppl 1):S49-52. doi: 10.1097/00061198-200110001-00018. J Glaucoma. 2001. PMID: 11890275 Review.

2

The relationship between structural and functional alterations in glaucoma: a review.

Johnson CA, Cioffi GA, Liebmann JR, Sample PA, Zangwill LM, Weinreb RN. Johnson CA, et al. Semin Ophthalmol. 2000 Dec;15(4):221-33. doi: 10.3109/08820530009037873. Semin Ophthalmol. 2000. PMID: 17585436 Review.

3

Progressive color visual field loss in glaucoma.

Sample PA, Weinreb RN. Sample PA, et al. Invest Ophthalmol Vis Sci. 1992 May;33(6):2068-71. Invest Ophthalmol Vis Sci. 1992. PMID: 1582812

4

Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.

Medeiros FA, Sample PA, Weinreb RN. Medeiros FA, et al. Am J Ophthalmol. 2004 May;137(5):863-71. doi: 10.1016/j.ajo.2003.12.009. Am J Ophthalmol. 2004. PMID: 15126151

5

Patterns of glaucomatous visual field progression identified by three progression criteria.

Boden C, Blumenthal EZ, Pascual J, McEwan G, Weinreb RN, Medeiros F, Sample PA. Boden C, et al. Am J Ophthalmol. 2004 Dec;138(6):1029-36. doi: 10.1016/j.ajo.2004.07.003. Am J Ophthalmol. 2004. PMID: 15629296

6

Relationship between patterns of visual field loss and retinal nerve fiber layer thickness measurements.

Hoffmann EM, Medeiros FA, Sample PA, Boden C, Bowd C, Bourne RR, Zangwill LM, Weinreb RN. Hoffmann EM, et al. Am J Ophthalmol. 2006 Mar;141(3):463-471. doi: 10.1016/j.ajo.2005.10.017. Am J Ophthalmol. 2006. PMID: 16490491

7

Visual function-specific perimetry to identify glaucomatous visual loss using three different definitions of visual field abnormality.

Tafreshi A, Sample PA, Liebmann JM, Girkin CA, Zangwill LM, Weinreb RN, Lalezary M, Racette L. Tafreshi A, et al. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1234-40. doi: 10.1167/iovs.08-2535. Epub 2008 Oct 31. Invest Ophthalmol Vis Sci. 2009. PMID: 18978349 Free PMC article.

8

Spatial characteristics of visual field progression determined by Monte Carlo simulation: diagnostic innovations in glaucoma study.

Pascual JP, Schiefer U, Paetzold J, Zangwill LM, Tavares IM, Weinreb RN, Sample PA. Pascual JP, et al. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1642-50. doi: 10.1167/iovs.06-0966. Invest Ophthalmol Vis Sci. 2007. PMID: 17389495

9

Comparison of HRT-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma.

Alencar LM, Bowd C, Weinreb RN, Zangwill LM, Sample PA, Medeiros FA. Alencar LM, et al. Invest Ophthalmol Vis Sci. 2008 May;49(5):1898-906. doi: 10.1167/iovs.07-0111. Invest Ophthalmol Vis Sci. 2008. PMID: 18436823 Free PMC article.

10

Short-wavelength automated perimetry: it's role in the clinic and for understanding ganglion cell function.

Sample PA. Sample PA. Prog Retin Eye Res. 2000 Jul;19(4):369-83. doi: 10.1016/s1350-9462(00)00001-x. Prog Retin Eye Res. 2000. PMID: 10785615 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results